Security record · archived quarter
ANAB
AnaptysBio, Inc. · Healthcare · Biotechnology
10Tracked holders
—Δ holders
1.82MShares held
$45.55MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 86 | +7 | 13.42M | $905.56M | +13 | −6 |
| Q1 2026 | 82 | +8 | 12.40M | $687.67M | +10 | −2 |
| Q4 2025 | 74 | -1 | 13.98M | $677.76M | — | −1 |
| Q3 2025 | 20 | +1 | 11.93M | $365.35M | +1 | — |
| Q2 2025 | 16 | 0 | 9.08M | $201.48M | +1 | −1 |
| Q1 2025 | 13 | +2 | 6.02M | $111.87M | +2 | — |
| Q4 2024 | 11 | -2 | 3.90M | $51.60M | — | −2 |
| Q3 2024 | 12 | +2 | 2.80M | $93.85M | +2 | — |
| Q2 2024 | 10 | — | 1.82M | $45.55M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Geode Capital Management ✦ (passive) | 452.06K | — | $11.33M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 452.06K | — | $11.33M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Millennium Management ✦ | 373.76K | — | $9.37M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 300.22K | — | $7.53M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 300.22K | — | $7.53M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | D. E. Shaw & Co. ✦ | 171.45K | — | $4.30M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | D. E. Shaw & Co. ✦ | 171.45K | — | $4.30M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Renaissance Technologies ✦ | 152.70K | — | $3.83M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Two Sigma Investments ✦ | 140.50K | — | $3.52M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Citadel Advisors ✦ | 80.98K | — | $2.03M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 80.98K | — | $2.03M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Fisher Asset Management ✦ | 64.99K | — | $1.63M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Wellington Management ✦ | 62.89K | — | $1.58M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Wellington Management ✦ | 62.89K | — | $1.58M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Point72 Asset Management ✦ | 17.90K | — | $448,574 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 205 holders, 28.23M shares, $1.54B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API